<DOC>
	<DOCNO>NCT02669134</DOCNO>
	<brief_summary>The main objective CRICKET study demonstrate AV VV optimization use SonR improve LV reverse remodel response CRT , compare 'Fixed Settings ' ( FS ) 6 month treatment . In investigator-initiated , multi-centre , 2:2 factorial design , randomize , two-arm , double-blinded , cross-over , prospective trial , CRT recipients randomize 'SonR ' atrioventricular ( AV ) ventricular-ventricular ( VV ) optimization 'fixed setting ' . The primary endpoint absolute reduction leave ventricular end-systolic volume .</brief_summary>
	<brief_title>CRT Improved Clinical Response UK Trial</brief_title>
	<detailed_description>This investigator-initiated , multi-centre , 2:2 factorial design , randomize , two-arm , double-blinded , cross-over , prospective trial Main study objectives The main objective CRICKET study demonstrate AV VV optimization use SonR improve LV reverse remodel response CRT , compare 'Fixed Settings ' ( FS ) 6 month treatment . Study endpoints Primary endpoint : The primary endpoint reduction ( absolute difference ) LVESV SonR v FS 6 month treatment . The difference intra-patient absolute change LVESV value compare two treatment : `` SonR optimization '' vs. `` FS '' , define sense AV delay 125 m , VV delay 0 m ( simultaneous ) . Secondary endpoint : Change 6 MWT distance Change NYHA class Change quality life Change patient global assessment ( EQ-5D ) Change Quality life ( MLWHF questionnaire ) Change LVEF AF burden Adverse Events Number subject Two hundred ( 200 ) patient enrol . All patient implant SonRtip bipolar atrial lead LivaNova ( Sorin ) CRT-D device offering SonR optimization algorithm atrio-biventricular pacing . Patients assign either treatment control arm , employ 1:1 randomization 100 patient 2 group : Study Group ( SonR CRT Optimization program `` AV+VV '' ) Control Group ( `` Fixed Settings '' ( FS ) , define sense AV delay 125 m , VV delay 0 m ( simultaneous ) ; SonR CRT Optimization program `` Off '' ) . After first 6 month , patient crossed-over alternative arm another 6 month . There washout period . Duration clinical investigation The study inclusion phase expect last approximately 1.5 year . Follow-ups Patients evaluated baseline randomize prior implantation SonR optimization FS . A clinical assessment , ECG echocardiography undertaken 6 month . At point , patient cross arm another 6 month . The study close follow clinical echocardiographic assessment 12 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Eligible implantation CRTD device accord current NICE ESC guideline ; In sinus rhythm ; NYHA class II , III IV Have review , sign date informed consent Inability 6 min walk test . Previous implant pacemaker , ICD CRT device ( except upgrade single chamber ICD fully functional defibrillation lead ) recall surveillance ) ; Persistent atrial arrhythmia ( cardioversion atrial fibrillation ) within past month ; Ventricular tachyarrhythmia transient reversible cause acute myocardial infarction ( MI ) , digitalis intoxication , drown , electrocution , electrolyte imbalance , hypoxia sepsis , uncorrected time enrolment ; Incessant ventricular tachyarrhythmia ; Unstable angina , acute MI , Coronary Artery BypassGrafting ( CABG ) , Percutaneous Coronary Intervention ( PCI ) within past 4 week ; Correctable valvular disease primary cause heart failure ; Indication valve repair replacement ; Recent CerebroVascular Accident ( CVA ) Transient Ischemic Attack ( TIA ) ( within previous 3 month ) ; On transplant wait list ; Previous heart transplant ; Already include another clinical study could confound result study ; Life expectancy less 1 year ; Inability understand purpose study ; Unavailability schedule followup refusal cooperate ; Age le 18 year ; Pregnancy ; Drug addiction abuse ; Under guardianship .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>cardiac resynchronization therapy</keyword>
	<keyword>optimization</keyword>
	<keyword>heart failure</keyword>
	<keyword>reverse leave ventricular remodeling</keyword>
</DOC>